Immutep

$2.07
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-1.45%) Today

+$0.03 (+1.47%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell Immutep and other stocks, options, and ETFs commission-free!

About IMMP

Immutep Limited American Depositary Shares, also called Immutep, is a biotechnology company, which engages in the research and development of immunotherapeutic treatments for cancer and autoimmune diseases. Its product is IMP321, which involves in clinical development for the treatment of breast cancer and melanoma. The company was founded on May 21, 1987 and is headquartered in Sydney, Australia. The listed name for IMMP is Immutep Limited American Depositary Shares.

CEO

Marc Voigt

Employees

—

Headquarters

Sydney, New South Wales (NSW)

Founded

1987

Market Cap

125.68M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

100.19K

High Today

$2.11

Low Today

$2.01

Open Price

$2.04

Volume

62.73K

52 Week High

$3.10

52 Week Low

$0.53

Collections

Research And Development

Medical

IMMP Earnings

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Estimated

— per share

Actual

Expected Dec 18, Pre-Market